
GE HealthCare has received FDA clearance for its Voluson Expert Series, a new line of AI-powered ultrasound systems designed to improve women’s healthcare, especially in managing high-risk pregnancies.
Addressing the Rise of High-Risk Pregnancies
Each year, 30,000 to 50,000 women in the U.S. experience pregnancy complications that could pose risks to both mother and baby. The Voluson Expert 22, 20, and 18 ultrasound systems aim to detect potential issues early through high-resolution imaging and AI-driven tools, improving diagnosis and treatment.
Key Features of the Voluson Expert Series
Advanced Imaging Technology
Lyric Architecture: Delivers clearer, more detailed images to help clinicians detect subtle anatomical features.
Expanded Color Doppler: Shows real-time blood flow patterns, helping identify abnormalities more easily.
AI-Powered Automation
SonoLyst Suite: Uses AI for image recognition, automatic annotations, and measurements, making exams faster and more accurate.
SonoLystLive: Supports real-time AI guidance for early pregnancy exams, ensuring all necessary views are captured.
SonoPelvicFloor 3.0: Cuts pelvic floor measurement exam times by up to 80%.
SonoAVCfollicle 2.0: Improves accuracy in follicle detection, helping assess fertility treatments.
Improving Women's Health with AI
The Voluson Expert Series integrates AI and automation to streamline ultrasound workflow, enhance image quality, and support clinicians in making informed decisions.
“We are proud to introduce these updates to the Voluson Expert ultrasound systems,” said Gerald Seifriedsberger, General Manager of Women’s Health at GE HealthCare. “By providing greater clarity and detail, we can empower healthcare professionals to transform women’s healthcare and improve outcomes for all.”
Comments